In the seventh episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Audrey Gibson, PA-C discuss the interplay between managed care and biosimilars.

The learning objectives for this episode are to:

• Discuss managed care implications for biosimilars reaching the market
• Identify the benefits of biosimilars in managed care
• Formulate strategies managed care professionals can employ to establish clinical pathways and increase biosimilar uptake in practice

Please take our evaluation regarding this podcast here:   https://www.ghapp.org/biosimilars-podcast-eval